We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
Cap. Flow
+$985M
Cap. Flow %
13.27%
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$49.3M
2
INTU icon
Intuit
INTU
+$48.7M
3
COST icon
Costco
COST
+$47.9M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$47.4M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$45.1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$41M
2
DG icon
Dollar General
DG
+$39M
3
BIIB icon
Biogen
BIIB
+$36.8M
4
IYR icon
iShares US Real Estate ETF
IYR
+$29.8M
5
WM icon
Waste Management
WM
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Consumer Discretionary 16.12%
3 Healthcare 11.21%
4 Financials 10.17%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRC
2951
DELISTED
First Republic Bank
FRC
-7,859
Closed -$833K
CIH
2952
DELISTED
China Index Holdings Limited American Depository Shares
CIH
-16,146
Closed -$35K
AGRX
2953
DELISTED
Agile Therapeutics
AGRX
-19
Closed -$108K
AUY
2954
DELISTED
Yamana Gold, Inc.
AUY
-47,618
Closed -$260K
ASPU
2955
DELISTED
ASPEN GROUP, INC.
ASPU
-24,237
Closed -$219K
ATCO
2956
DELISTED
Atlas Corp.
ATCO
-13,725
Closed -$104K
SIOX
2957
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-29,876
Closed -$84K
OBSV
2958
DELISTED
ObsEva SA Ordinary Shares
OBSV
-23,905
Closed -$141K
IAA
2959
DELISTED
IAA, Inc. Common Stock
IAA
-15,708
Closed -$606K
RFP
2960
DELISTED
Resolute Forest Products Inc.
RFP
-61,525
Closed -$130K
VIVO
2961
DELISTED
Meridian Bioscience Inc
VIVO
-36,745
Closed -$856K
TTM
2962
DELISTED
Tata Motors Limited
TTM
-41,605
Closed -$273K
HTGM
2963
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
-70
Closed -$9K
ELOX
2964
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
-342
Closed -$41K
TWTR
2965
DELISTED
Twitter, Inc.
TWTR
-607,517
Closed -$18.1M
HNGR
2966
DELISTED
Hanger Inc.
HNGR
-20,930
Closed -$347K
TYME
2967
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
-56,480
Closed -$75K
ALNA
2968
DELISTED
Allena Pharmaceuticals
ALNA
-51,524
Closed -$81K
POLY
2969
DELISTED
Plantronics, Inc.
POLY
-12,319
Closed -$181K
ENDP
2970
DELISTED
Endo International plc
ENDP
-141,560
Closed -$486K
EMWP
2971
DELISTED
Eros Media World PLC
EMWP
-11,178
Closed -$706K
ACC
2972
DELISTED
American Campus Communities, Inc.
ACC
-29,102
Closed -$1.02M
NPTN
2973
DELISTED
NEOPHOTONICS CORP
NPTN
-18,500
Closed -$164K
ENIA
2974
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
-13,740
Closed -$103K
VNE
2975
DELISTED
Veoneer, Inc.
VNE
-13,259
Closed -$142K

Similar funds

Squarepoint's Q3 2020 Portfolio in Review

As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.

  • Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
  • Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
  • Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
  • Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
  • Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
  • Squarepoint opened 854 new positions and closed 600 in Q3 2020.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.